Your session is about to expire
← Back to Search
Cardiovascular Conditioning Protocol for Treatment
Study Summary
This trial will compare a new cardiovascular training protocol to traditional voice production training to see which is more effective at alleviating symptoms of vocal fatigue in teachers.
- Vocal Fatigue
- Treatment
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many participants are being treated in this research endeavor?
"Indeed, the information available on clinicaltrials.gov suggests that recruitment is still ongoing for this medical trial. Initially posted in April of 2020 with a June 15th 2022 update, the study seeks out 52 patients at one location."
Am I eligible to participate in the trial?
"This clinical trial seeks out 52 individuals aged between 21 and 45, with the following inclusion criteria: female educators in the age range of 21-60 years old; a score higher or equal to 15 on factor 1 of VFI (voice fatigue index) or lower than 5 on factor 3 of VFI (symptomatic amelioration through rest); and sedentary lifestyle - participants should be engaging in light intensity cardio exercise fewer than 150 minutes over less than five days per week."
Does this trial extend to those aged 45 and above?
"To be eligible for this study, potential participants must have an age between 21 and 45. For those under 18 or over 65 years old, there are currently 21 trials available and 192 studies respectively."
Is the enrollment phase for this experiment still open?
"Affirmative. According to clinicaltrials.gov, this medical research is currently recruiting participants; it was initially posted on the 4th of February 2020 and most recently updated on 15th June 2022. There are 52 patients that need to be enrolled in a single site for this trial."
Share this study with friends
Copy Link
Messenger